ShenGY
2021-11-15
👍
McKesson, drug distributors face $95 billion opioid trial in Washington state<blockquote>McKesson和药品经销商在华盛顿州面临价值950亿美元的阿片类药物试验</blockquote>
免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP，发表看法
APP内打开
发表看法
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":873470772,"tweetId":"873470772","gmtCreate":1636982241351,"gmtModify":1636982783346,"author":{"id":4099261143755430,"idStr":"4099261143755430","authorId":4099261143755430,"authorIdStr":"4099261143755430","name":"ShenGY","avatar":"https://static.tigerbbs.com/e3a5b601d7373e94cf8257ec4aec4f52","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":11,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":1,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>👍</p></body></html>","htmlText":"<html><head></head><body><p>👍</p></body></html>","text":"👍","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/873470772","repostId":1189924614,"repostType":4,"repost":{"id":"1189924614","kind":"news","pubTimestamp":1636976498,"share":"https://www.laohu8.com/m/news/1189924614?lang=zh_CN&edition=full","pubTime":"2021-11-15 19:41","market":"us","language":"en","title":"McKesson, drug distributors face $95 billion opioid trial in Washington state<blockquote>McKesson和药品经销商在华盛顿州面临价值950亿美元的阿片类药物试验</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1189924614","media":"Reuters","summary":"A trial pitting Washington state against McKesson Corp(MCK.N)and two other drug distributors accused","content":"<p>A trial pitting Washington state against McKesson Corp(MCK.N)and two other drug distributors accused of fueling the U.S. opioid epidemic is slated to kick off on Monday, after the state's attorney general declined to join a $26 billion nationwide settlement.</p><p><blockquote>华盛顿州与McKesson Corp(MCK.N)和另外两家被指控助长美国阿片类药物流行的药品经销商定于周一开始，此前该州总检察长拒绝加入260亿美元的全国和解协议。</blockquote></p><p> Washington Attorney General Bob Ferguson has accused McKesson, Cardinal Health Inc(CAH.N)and AmerisourceBergen Corp(ABC.N)of creating a public nuisance by failing to prevent the diversion of prescription pills into illegal channels.</p><p><blockquote>华盛顿司法部长鲍勃·弗格森指控麦克森、康德乐公司(CAH.N)和AmerisourceBergen Corp(ABC.N)未能阻止处方药流入非法渠道，造成公害。</blockquote></p><p> Washington is seeking $38.2 billion to fund treatment and other programs and billions more in penalties and forfeited profits. The distributors, who deny wrongdoing, say the state wants a \"wildly inflated recovery\" of more than $95 billion.</p><p><blockquote>华盛顿正在寻求382亿美元来资助治疗和其他项目，以及数十亿美元的罚款和没收利润。否认有不当行为的分销商表示，该州希望获得超过950亿美元的“疯狂复苏”。</blockquote></p><p> More than 3,300 lawsuits by largely state and local governments have been filed seeking to hold those and other companies responsible for a drug abuse crisis the U.S. government says led to nearly 500,000 opioid overdose deaths over two decades.</p><p><blockquote>主要由州和地方政府提起的3,300多起诉讼，寻求追究这些公司和其他公司对药物滥用危机的责任。美国政府称，这场危机导致20年来近50万人因阿片类药物过量死亡。</blockquote></p><p> Washington state would have been eligible for $527.5 million if it had joined a proposed global deal, under which the distributors would pay up to$21 billionand drugmaker Johnson & Johnson(JNJ.N)would pay $5 billion to resolve the cases.</p><p><blockquote>如果华盛顿州加入一项拟议的全球协议，它将有资格获得5.275亿美元，根据该协议，分销商将支付最多210亿美元，制药商强生公司(JNJ.N)将支付50亿美元来解决这些案件。</blockquote></p><p> Ferguson, a Democrat, has criticized the settlement as \"not nearly good enough,\" saying the nearly $30 million on average the state and its communities would receive annually was insufficient to address the devastation caused by the epidemic.</p><p><blockquote>民主党人弗格森批评该和解协议“远远不够好”，称该州及其社区平均每年收到的近3000万美元不足以解决疫情造成的破坏。</blockquote></p><p> The state became one of eight to not participate in the distributors' nationwide accord and opted to proceed to trial.</p><p><blockquote>该州成为八个不参与经销商全国协议并选择继续审判的州之一。</blockquote></p><p> \"Washington families devastated by the opioid epidemic deserve their day in court,\" Ferguson said in a statement.</p><p><blockquote>弗格森在一份声明中说：“因阿片类药物流行而遭受重创的华盛顿家庭应该在法庭上度过一天。”</blockquote></p><p> The companies deny wrongdoing, arguing that the increase in pills was due to rising prescriptions and other factors and that they had systems in place to prevent drug diversion. They argue that distributing regulated drugs cannot support a public nuisance claim.</p><p><blockquote>这些公司否认有不当行为，辩称药丸的增加是由于处方增加和其他因素，并且他们有防止药物转移的系统。他们认为，分发受管制药物不能支持公害索赔。</blockquote></p><p> Plaintiffs in some of the other opioid cases have recently faced setbacks pursuing nuisance claims.</p><p><blockquote>其他一些阿片类药物案件的原告最近在寻求妨害索赔时面临挫折。</blockquote></p><p> Oklahoma's top court on Tuesday overturned a $465 million judgment against J&J, and a California judge this month ruled in favor of four drugmakers in a case brought by several large counties.</p><p><blockquote>俄克拉荷马州最高法院周二推翻了对强生公司4.65亿美元的判决，加州法官本月在几个大县提起的案件中做出了有利于四家制药商的裁决。</blockquote></p><p> The distributors are awaiting a decision in a similar case in West Virginia following a trial. Closing arguments are expected Monday in Ohio in the first trial pharmacies have faced over the epidemic.</p><p><blockquote>经销商正在等待西弗吉尼亚州类似案件的审判判决。预计周一将在俄亥俄州进行结案陈词，这是药店因疫情而面临的首次审判。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>McKesson, drug distributors face $95 billion opioid trial in Washington state<blockquote>McKesson和药品经销商在华盛顿州面临价值950亿美元的阿片类药物试验</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMcKesson, drug distributors face $95 billion opioid trial in Washington state<blockquote>McKesson和药品经销商在华盛顿州面临价值950亿美元的阿片类药物试验</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Reuters</strong><span class=\"h-time small\">2021-11-15 19:41</span>\n</p>\n</h4>\n</header>\n<article>\n<p>A trial pitting Washington state against McKesson Corp(MCK.N)and two other drug distributors accused of fueling the U.S. opioid epidemic is slated to kick off on Monday, after the state's attorney general declined to join a $26 billion nationwide settlement.</p><p><blockquote>华盛顿州与McKesson Corp(MCK.N)和另外两家被指控助长美国阿片类药物流行的药品经销商定于周一开始，此前该州总检察长拒绝加入260亿美元的全国和解协议。</blockquote></p><p> Washington Attorney General Bob Ferguson has accused McKesson, Cardinal Health Inc(CAH.N)and AmerisourceBergen Corp(ABC.N)of creating a public nuisance by failing to prevent the diversion of prescription pills into illegal channels.</p><p><blockquote>华盛顿司法部长鲍勃·弗格森指控麦克森、康德乐公司(CAH.N)和AmerisourceBergen Corp(ABC.N)未能阻止处方药流入非法渠道，造成公害。</blockquote></p><p> Washington is seeking $38.2 billion to fund treatment and other programs and billions more in penalties and forfeited profits. The distributors, who deny wrongdoing, say the state wants a \"wildly inflated recovery\" of more than $95 billion.</p><p><blockquote>华盛顿正在寻求382亿美元来资助治疗和其他项目，以及数十亿美元的罚款和没收利润。否认有不当行为的分销商表示，该州希望获得超过950亿美元的“疯狂复苏”。</blockquote></p><p> More than 3,300 lawsuits by largely state and local governments have been filed seeking to hold those and other companies responsible for a drug abuse crisis the U.S. government says led to nearly 500,000 opioid overdose deaths over two decades.</p><p><blockquote>主要由州和地方政府提起的3,300多起诉讼，寻求追究这些公司和其他公司对药物滥用危机的责任。美国政府称，这场危机导致20年来近50万人因阿片类药物过量死亡。</blockquote></p><p> Washington state would have been eligible for $527.5 million if it had joined a proposed global deal, under which the distributors would pay up to$21 billionand drugmaker Johnson & Johnson(JNJ.N)would pay $5 billion to resolve the cases.</p><p><blockquote>如果华盛顿州加入一项拟议的全球协议，它将有资格获得5.275亿美元，根据该协议，分销商将支付最多210亿美元，制药商强生公司(JNJ.N)将支付50亿美元来解决这些案件。</blockquote></p><p> Ferguson, a Democrat, has criticized the settlement as \"not nearly good enough,\" saying the nearly $30 million on average the state and its communities would receive annually was insufficient to address the devastation caused by the epidemic.</p><p><blockquote>民主党人弗格森批评该和解协议“远远不够好”，称该州及其社区平均每年收到的近3000万美元不足以解决疫情造成的破坏。</blockquote></p><p> The state became one of eight to not participate in the distributors' nationwide accord and opted to proceed to trial.</p><p><blockquote>该州成为八个不参与经销商全国协议并选择继续审判的州之一。</blockquote></p><p> \"Washington families devastated by the opioid epidemic deserve their day in court,\" Ferguson said in a statement.</p><p><blockquote>弗格森在一份声明中说：“因阿片类药物流行而遭受重创的华盛顿家庭应该在法庭上度过一天。”</blockquote></p><p> The companies deny wrongdoing, arguing that the increase in pills was due to rising prescriptions and other factors and that they had systems in place to prevent drug diversion. They argue that distributing regulated drugs cannot support a public nuisance claim.</p><p><blockquote>这些公司否认有不当行为，辩称药丸的增加是由于处方增加和其他因素，并且他们有防止药物转移的系统。他们认为，分发受管制药物不能支持公害索赔。</blockquote></p><p> Plaintiffs in some of the other opioid cases have recently faced setbacks pursuing nuisance claims.</p><p><blockquote>其他一些阿片类药物案件的原告最近在寻求妨害索赔时面临挫折。</blockquote></p><p> Oklahoma's top court on Tuesday overturned a $465 million judgment against J&J, and a California judge this month ruled in favor of four drugmakers in a case brought by several large counties.</p><p><blockquote>俄克拉荷马州最高法院周二推翻了对强生公司4.65亿美元的判决，加州法官本月在几个大县提起的案件中做出了有利于四家制药商的裁决。</blockquote></p><p> The distributors are awaiting a decision in a similar case in West Virginia following a trial. Closing arguments are expected Monday in Ohio in the first trial pharmacies have faced over the epidemic.</p><p><blockquote>经销商正在等待西弗吉尼亚州类似案件的审判判决。预计周一将在俄亥俄州进行结案陈词，这是药店因疫情而面临的首次审判。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.reuters.com/world/us/mckesson-drug-distributors-face-95-billion-opioid-trial-washington-state-2021-11-15/\">Reuters</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MCK":"麦克森药物批发","JNJ":"强生"},"source_url":"https://www.reuters.com/world/us/mckesson-drug-distributors-face-95-billion-opioid-trial-washington-state-2021-11-15/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1189924614","content_text":"A trial pitting Washington state against McKesson Corp(MCK.N)and two other drug distributors accused of fueling the U.S. opioid epidemic is slated to kick off on Monday, after the state's attorney general declined to join a $26 billion nationwide settlement.\nWashington Attorney General Bob Ferguson has accused McKesson, Cardinal Health Inc(CAH.N)and AmerisourceBergen Corp(ABC.N)of creating a public nuisance by failing to prevent the diversion of prescription pills into illegal channels.\nWashington is seeking $38.2 billion to fund treatment and other programs and billions more in penalties and forfeited profits. The distributors, who deny wrongdoing, say the state wants a \"wildly inflated recovery\" of more than $95 billion.\nMore than 3,300 lawsuits by largely state and local governments have been filed seeking to hold those and other companies responsible for a drug abuse crisis the U.S. government says led to nearly 500,000 opioid overdose deaths over two decades.\nWashington state would have been eligible for $527.5 million if it had joined a proposed global deal, under which the distributors would pay up to$21 billionand drugmaker Johnson & Johnson(JNJ.N)would pay $5 billion to resolve the cases.\nFerguson, a Democrat, has criticized the settlement as \"not nearly good enough,\" saying the nearly $30 million on average the state and its communities would receive annually was insufficient to address the devastation caused by the epidemic.\nThe state became one of eight to not participate in the distributors' nationwide accord and opted to proceed to trial.\n\"Washington families devastated by the opioid epidemic deserve their day in court,\" Ferguson said in a statement.\nThe companies deny wrongdoing, arguing that the increase in pills was due to rising prescriptions and other factors and that they had systems in place to prevent drug diversion. They argue that distributing regulated drugs cannot support a public nuisance claim.\nPlaintiffs in some of the other opioid cases have recently faced setbacks pursuing nuisance claims.\nOklahoma's top court on Tuesday overturned a $465 million judgment against J&J, and a California judge this month ruled in favor of four drugmakers in a case brought by several large counties.\nThe distributors are awaiting a decision in a similar case in West Virginia following a trial. Closing arguments are expected Monday in Ohio in the first trial pharmacies have faced over the epidemic.","news_type":1,"symbols_score_info":{"JNJ":0.9,"MCK":0.9}},"isVote":1,"tweetType":1,"viewCount":1997,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":2,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/873470772"}
精彩评论